10 Best Penny Stocks That Could Skyrocket in 2026
In this article, we look at the 10 Best Penny Stocks That Could Skyrocket in 2026. Penny stocks can deliver dramatic gains when a business achieves a milestone that investors had discounted.
Humacyte Inc. (HUMA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Antipodes Partners Jacob Mitchell | 10,103,647 | $7,884,886 | +77% | 0.14% |
| 2. | Alyeska Investment Group Anand Parekh | 6,022,925 | $4,700,291 | 0.01% | |
| 3. | Davidson Kempner Thomas Lenox Kempner | 5,000,000 | $3,902,000 | 0.05% | |
| 4. | Great Point Partners Jeffrey Jay And David Kroin | 3,750,000 | $2,926,500 | 0.55% | |
| 5. | AQR Capital Management Cliff Asness | 2,597,134 | $2,026,801 | +35% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.56 | 10,000 | $5,620.00 | 50,000 | 2026-09-14 | Filing | |
| $0.69 | 10,000 | $6,930.00 | 40,000 | 2026-08-20 | Filing | |
| $0.59 | 30,000 | $17,820.00 | 30,000 | 2026-08-17 | Filing | |
| $0.88 | 56,818 | $49,999.84 | 148,025 | 2026-05-19 | Filing | |
| $0.89 | 11,000 | $9,839.50 | 43,950 | 2026-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.90 | 45,887 | $41,146.87 | 267,213 | 2026-05-18 | Filing | |
| $0.90 | 45,887 | $41,146.87 | 272,713 | 2026-05-18 | Filing | |
| $1.58 | 591,685 | $934,862.30 | 0 | 2025-08-20 | Filing | |
| $1.63 | 1,100,000 | $1,793,000.00 | 591,685 | 2025-08-19 | Filing | |
| $1.83 | 549,360 | $1,005,328.80 | 1,691,685 | 2025-08-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 71,479 | $37,005 | 0% | |
| 2. | 46,545 | $18,865 | 0.01% | |
| 3. | 21,958 | $11,368 | 0.01% | |
| 4. | 16,500 | $8,542 | 0% | |
| 5. | 15,400 | $7,973 | 0% |
News See All
11 Best 52-Week Low Penny Stocks to Invest In
In this article, we look at the 11 Best 52-Week Low Penny Stocks to Invest In.
Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercialization
We recently compiled a list of the 10 Best Penny Stocks Under $1 According to Hedge Funds. Humacyte, Inc. (NASDAQ:HUMA) is among the best penny stocks under $1 according to hedge funds.
10 Best Penny Stocks Under $1 According to Hedge Funds
In this article, we will be taking a look at the 10 Best Penny Stocks Under $1 According to Hedge Funds.
Humacyte, Inc. (NASDAQ:HUMA) Q1 2026 Earnings Call Transcript
Humacyte, Inc. (NASDAQ:HUMA) Q1 2026 Earnings Call Transcript May 13, 2026Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1.
11 Best High Volume Penny Stocks to Buy Now
In this article, we will look at the 11 Best High Volume Penny Stocks to Buy Now.
Humacyte (HUMA): Benchmark Remains Bullish on Stock
Humacyte, Inc. (NASDAQ:HUMA) is one of the Best Micro-Cap Stocks to Invest in According to Analysts. In mid-November, Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte, Inc.
11 Best Micro-Cap Stocks to Invest in According to Analysts
In this article, we discuss the 11 best micro-cap stocks to invest in according to analysts.
Humacyte, Inc. (NASDAQ:HUMA) Q3 2025 Earnings Call Transcript
Humacyte, Inc. (NASDAQ:HUMA) Q3 2025 Earnings Call Transcript November 12, 2025Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.17.
Humacyte, Inc. (NASDAQ:HUMA) Q2 2025 Earnings Call Transcript
Humacyte, Inc. (NASDAQ:HUMA) Q2 2025 Earnings Call Transcript August 11, 2025Humacyte, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $-0.15.
Hedge Fund Resource Center